Reagents and consumables for HPV/CT/NG testing

Ended Awarded Last action

Contract number
36C25220A0031
Awardee
Awarding agency
Task orders
10 $1,666,134 obligated

Award facts

Opportunity
  • 36C25220Q0657 Solicitation number
Combined order value
$1,666,134 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 90% used
$1,852,813.60
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

This Blanket Purchase Agreement (BPA) was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency under the U.S. Department of Veterans Affairs (VA), to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract, valued at a total ceiling of $1,852,813.60, is for the provision of reagents and consumables for testing related to human papillomavirus (HPV), chlamydia (CT), and gonorrhea (NG). The contract is not designated as a set-aside and is established under Roche's existing General Services Administration (GSA) Schedule contracts, specifically the Critical Analyzers, Laboratory (FSS-66-III) and In Vitro Diagnostics, Reagents, Test (FSS-65-VII) schedules. This BPA provides a streamlined mechanism for the VA to acquire essential medical testing supplies and equipment from Roche Diagnostics, a leading provider of these products and services to federal healthcare agencies. The contract has a period of performance through March 31, 2026 and includes multiple task orders with fixed-price pricing structures.

The contracted products and services aim to support the VA's medical diagnostic testing needs, particularly for conditions such as HPV, chlamydia, and gonorrhea. As a global leader in in vitro diagnostics, Roche Diagnostics offers a comprehensive range of laboratory equipment, testing systems, reagents, and related services that enable federal healthcare agencies to efficiently access advanced medical technologies. The BPA allows the VA to acquire these critical testing supplies and consumables on an ongoing basis through pre-negotiated pricing and terms, supporting the delivery of healthcare services across the VA's healthcare system.

Task orders

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00007 $0
Exercise an Option P00006 $0
Exercise an Option P00005 $0
Other Administrative Action P00004 $0
Exercise an Option P00003 $0
Other Administrative Action P00002 $0
Exercise an Option P00001 $0
Original award $0

Quick answers

Who was awarded contract 36C25220A0031?

36C25220A0031 was awarded to Roche Diagnostics Corporation by Veterans Integrated Service Network 12 (Veterans Health Administration) on October 1, 2020.

How much is contract 36C25220A0031 worth?

Orders under 36C25220A0031 have obligated $1,666,134. 36C25220A0031's own ceiling is $1,852,814.

How many orders have been placed under contract 36C25220A0031?

10 orders have been placed under 36C25220A0031, the latest on October 1, 2025.

Who can order from contract 36C25220A0031?

36C25220A0031 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36C25220A0031 under another contract?

Yes. 36C25220A0031 is a blanket purchase agreement under V797D70105, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).

Was contract 36C25220A0031 competed?

The extent of competition for 36C25220A0031 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV